105 results
Page 2 of 6
8-K
EX-10.1
vijeuqp3o 7zig
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
tqzsa0l
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
EX-10.1
g3xhj j09c7z5i9gc16y
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
blp6no5pcx55eu 86
16 Dec 22
Prospectus supplement for primary offering
7:00am
8-K
EX-99.1
8csy8zv94ac8f6b
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
4x7g4kslk89
16 Jun 22
Other Events
7:45am
8-K
EX-99.1
i10tbpamhe36t5p
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm
8-K
EX-99.1
fu8x 1vjm5
28 Mar 22
Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
7:53am